World's Best Scientists 2026 revealed!
Award Badge
Microbiology
USA
2026

D-Index & Metrics

Microbiology

D-Index
157
Citations
86662
World Ranking
20
National Ranking
11

Medicine

D-Index
157
Citations
86609
World Ranking
890
National Ranking
507

Research.com Recognitions

  • 2026 - Research.com Microbiology in United States Leader Award
  • 2019 - Fellow, National Academy of Inventors
  • 2014 - Fellow of the American Academy of Arts and Sciences
  • 2012 - Member of the National Academy of Medicine (NAM)
  • 2006 - Robert Koch Prize
  • 2006 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Microbiology and Immunology
  • 2000 - Member of the National Academy of Sciences
  • 1997 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Peter Palese is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their primary research focus spans across medicine with significant contributions to epidemiology, infectious diseases, immunology, animal science and zoology, and molecular biology.

The scientist's recent scholarly output includes notable papers such as:

  • A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial, 2020, Nature Medicine
  • A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice, 2020, Molecular Therapy
  • Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19, 2020, The Lancet
  • Broadly neutralizing antibodies target a haemagglutinin anchor epitope, 2021, Nature
  • Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial, 2022, Nature Medicine

Collaborative work features frequent co-authorship with several researchers, including Florian Krammer, Weina Sun, Adolfo García-Sastre, Stefan Slamanig, and Raffael Nachbagauer. These collaborations have contributed to a broad portfolio of impactful publications.

Peter Palese has contributed extensively to various scientific venues. The most frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Proceedings of the National Academy of Sciences
  • Vaccine
  • mBio

The main fields and subfields studied by the scientist include:

  • Medicine
  • Epidemiology
  • Infectious Diseases
  • Immunology
  • Animal Science and Zoology
  • Molecular Biology

The core research topics address:

  • Influenza Virus Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory viral infections research
  • Animal Virus Infections Studies
  • Immune Cell Function and Interaction
  • Immune Response and Inflammation
  • Virology and Viral Diseases

Recognition of Peter Palese's contributions includes multiple awards, such as:

  • Fellow, National Academy of Inventors (2019)
  • Fellow of the American Academy of Arts and Sciences (2014)
  • Member of the National Academy of Medicine (NAM) (2012)
  • German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina - Nationale Akademie der Wissenschaften, Microbiology and Immunology (2006)
  • Robert Koch Prize (2006)
  • Member of the National Academy of Sciences (2000)
  • Fellow of the American Association for the Advancement of Science (AAAS) (1997)

Best Publications

  • Influenza virus transmission is dependent on relative humidity and temperature.

    Anice C Lowen;Samira Mubareka;John Steel;Peter Palese

  • Characterization of the reconstructed 1918 Spanish influenza pandemic virus

    Terrence M. Tumpey;Christopher F. Basler;Patricia V. Aguilar;Hui Zeng

  • THE BIOLOGY OF INFLUENZA VIRUSES

    Nicole M. Bouvier;Peter Palese

  • A novel influenza A virus mitochondrial protein that induces cell death

    Weisan Chen;Paul A. Calvo;Daniela Malide;James Gibbs

  • Influenza

    Unknown

  • Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

    Adolfo García-Sastre;Andrej Egorov;Demetrius Matassov;Sabine Brandt

  • Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

    Peter Palese;Kiyotake Tobita;Masahiro Ueda;Richard W. Compans

  • Rescue of Influenza A Virus from Recombinant DNA

    Ervin Fodor;Louise Devenish;Othmar G. Engelhardt;Peter Palese

  • Human host factors required for influenza virus replication

    Renate König;Silke Stertz;Yingyao Zhou;Atsushi Inoue

  • Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

    David J DiLillo;Gene S Tan;Peter Palese;Jeffrey V Ravetch

  • Influenza: old and new threats.

    Peter Palese

  • Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy

    Dmitriy Zamarin;Dmitriy Zamarin;Rikke B. Holmgaard;Rikke B. Holmgaard;Sumit K. Subudhi;Joon Seok Park;Joon Seok Park

  • Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein

    Julie Talon;Curt M. Horvath;Rosalind Polley;Christopher F. Basler

  • Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon

    Xiuyan Wang;Ming Li;Hongyong Zheng;Thomas Muster

  • Glycan Microarray Analysis of the Hemagglutinins from Modern and Pandemic Influenza Viruses Reveals Different Receptor Specificities

    James Stevens;Ola Blixt;Laurel Glaser;Jeffery K. Taubenberger

  • Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists

    Sarah A. Kopecky-Bromberg;Luis Martínez-Sobrido;Matthew Frieman;Ralph A. Baric

  • Pathogenicity of Influenza Viruses with Genes from the 1918 Pandemic Virus: Functional Roles of Alveolar Macrophages and Neutrophils in Limiting Virus Replication and Mortality in Mice

    Terrence M. Tumpey;Adolfo García-Sastre;Jeffery K. Taubenberger;Peter Palese

  • A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission

    Terrence M. Tumpey;Taronna R. Maines;Neal Van Hoeven;Laurel Glaser

  • Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N

    John Steel;Anice C. Lowen;Samira Mubareka;Peter Palese

  • Structure of the Uncleaved Human H1 Hemagglutinin from the Extinct 1918 Influenza Virus

    James Stevens;Adam L. Corper;Christopher F. Basler;Jeffery K. Taubenberger

  • Amplification, expression, and packaging of a foreign gene by influenza virus

    Willem Luytjes;Mark Krystal;Masayoshi Enami;Jeffrey D. Parvin

  • RAPID COMMUNICATION Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

    Adolfo Garcõ Âa-Sastre;Andrej Egorov;Demetrius Matassov;Sabine Brandt

Frequent Co-Authors

Adolfo García-Sastre
Adolfo García-Sastre Icahn School of Medicine at Mount Sinai
Florian Krammer
Florian Krammer Icahn School of Medicine at Mount Sinai
Mark Krystal
Mark Krystal ViiV Healthcare (United Kingdom)
Christopher F. Basler
Christopher F. Basler University of Georgia
Randy A. Albrecht
Randy A. Albrecht Icahn School of Medicine at Mount Sinai
Jeffrey D. Parvin
Jeffrey D. Parvin The Ohio State University
David E. Swayne
David E. Swayne United States Department of Agriculture
Patrick C. Wilson
Patrick C. Wilson Cornell University
Terrence M. Tumpey
Terrence M. Tumpey Centers for Disease Control and Prevention
Thomas M. Moran
Thomas M. Moran Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always start with medical school. Many students pursue alternative health care pathways online that can offer more flexibility and specialized training. For example, medical billing and coding schools that accept fafsa provide convenient entry points into healthcare administration, with the added benefit of financial aid options.

For those interested in patient care, some are curious: do you have to take a teas test for lpn? Fortunately, there are nursing programs that don’t require the TEAS or HESI exams, making the admission process less stressful.

Leadership roles in healthcare are increasingly popular. Earning a health care administration degree online can prepare you for high-demand management positions in hospitals and clinics.

Nurses aiming to advance their careers might consider specialized programs such as asn to np bridge programs. These online options allow registered nurses to quickly progress towards becoming nurse practitioners.

Best Scientists Citing Peter Palese

Trending Scientists

Recently Published Articles